Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

Lower zinc levels may predict less effective hair loss treatment.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Balancing testosterone may reduce COVID-19 severity.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

High androgen levels can cause hirsutism and increase inflammation.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Men with early baldness often have low vitamin D levels.

Use finasteride over dutasteride for hair loss; consider topical treatments and weigh risks.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Drugs penetrate scalp skin better than abdominal skin, with scalp hair follicles aiding in higher drug delivery.